Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer

PURPOSE: Chemohormonal therapy with docetaxel and androgen deprivation therapy (ADT+D) for metastatic hormone-sensitive prostate cancer improves overall survival as compared with androgen deprivation therapy (ADT) alone. We compared the quality of life (QOL) between patients with metastatic hormone-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Morgans, Alicia K., Chen, Yu-Hui, Sweeney, Christopher J., Jarrard, David F., Plimack, Elizabeth R., Gartrell, Benjamin A., Carducci, Michael A., Hussain, Maha, Garcia, Jorge A., Cella, David, DiPaola, Robert S., Patrick-Miller, Linda J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2018
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891128/
https://ncbi.nlm.nih.gov/pubmed/29522362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.75.3335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados